Cormorant Asset Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.1M Sell
190,000
-85,000
-31% -$13.1M 1.57% 18
2025
Q4
$47.9M Sell
275,000
-155,000
-36% -$28.3M 2.71% 14
2025
Q3
$61.9M Sell
430,000
-110,000
-20% -$13.5M 4.27% 9
2025
Q2
$54.3M Buy
540,000
+15,000
+3% +$1.15M 4.05% 7
2025
Q1
$40.1M Sell
525,000
-125,000
-19% -$9.56M 3.03% 9
2024
Q4
$44.9M Buy
650,000
+150,000
+30% +$10.8M 2.46% 10
2024
Q3
$36.5M Sell
500,000
-175,000
-26% -$12.9M 1.94% 18
2024
Q2
$45.2M Buy
675,000
+100,000
+17% +$3.88M 2.63% 12
2024
Q1
$15.6M Hold
575,000
0.69% 37
2023
Q4
$17.8M Hold
575,000
0.85% 30
2023
Q3
$14.5M Buy
+575,000
New +$13.2M 0.85% 29
2021
Q3
Sell
-250,000
Closed -$7.12M 95
2021
Q2
$7.12M Sell
250,000
-50,000
-17% -$1.48M 0.28% 74
2021
Q1
$10.2M Hold
300,000
0.29% 73
2020
Q4
$9.99M Sell
300,000
-50,000
-14% -$1.83M 0.29% 65
2020
Q3
$11.2M Sell
350,000
-100,000
-22% -$2.87M 0.49% 53
2020
Q2
$12.4M Buy
450,000
+87,727
+24% +$2.08M 0.54% 53
2020
Q1
$5.81M Buy
+362,273
New +$8.59M 0.33% 56

Other funds holding INSM